Source: Town Hall
by Stephen Moore
“For every drug approved by the Food and Drug Administration, there are nearly a dozen that fail and lose money for investors. The rare wonder drug ‘hits’ have to pay off to cover the cost of the much more common dead-end research — the ‘misses.’ The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be sold to U.S. consumers.” (03/18/25)